Abstract
Background and Objective: Vitamin D deficiency is internationally recognized among the potentially modifiable risk factors for ischemic cardio-cerebrovascular diseases. However, the association between vitamin D deficiency and stroke morbidity or mortality remains insufficiently known. Our aim is to investigate their relevance to 25-hydroxyvitamin D [25(OH) D] levels and clinical severity and outcome after 3 months in first-ever ischemic stroke.
Methods: Retrospective analysis of 356 consecutive patients in first-ever ischemic stroke between 2013 and 2015. Serum 25(OH) D levels were measured at baseline. Stroke severity was assessed at admission using the National Institutes of Health Stroke Scale (NIHSS) score. Functional outcome after 3 months of onset was evaluated using the modified Rankin scale (mRS).
Results: Among the 356 enrolled patients, HbA1c was higher in insufficiency/deficiency group than that in the sufficiency group (6.3 ± 1.7 vs. 5.9 ± 1.1, p =0.015). The hospital stay was longer in insufficiency/deficiency group than that in the sufficiency group (11 (8-17) vs. 9.5 (7-13), p = 0.035). There was a significant inversed trend between serum 25(OH) D levels and hospital stay (OR 0.960, P = 0.031), using logistic regression.
Conclusion: 25(OH)D levels are associated with glucose homeostasis, 25(OH) D contributes to increase the length of hospital stay. Low serum 25-OHD level is an independent predictor for hospital stay in first-ever ischemic stroke. Vitamin D deficiency did not predict functional outcome in the span of 3 months.
Keywords: 25-hydroxyvitamin D, first-ever ischemic stroke, hospital stay, functional outcome, mortality, vitamin D.
[http://dx.doi.org/10.2165/11593080-000000000-00000] [PMID: 21790207]
[http://dx.doi.org/10.1161/STROKEAHA.114.007706] [PMID: 25424481]
[http://dx.doi.org/10.1042/CS20130284] [PMID: 24020395]
[http://dx.doi.org/10.1161/STROKEAHA.111.636910] [PMID: 22442173]
[http://dx.doi.org/10.1159/000362534] [PMID: 24970287]
[http://dx.doi.org/10.1111/j.1468-1331.2012.03758.x] [PMID: 22632854]
[http://dx.doi.org/10.1111/ene.12731] [PMID: 25962507]
[http://dx.doi.org/10.1016/j.nut.2011.10.015] [PMID: 22261577]
[http://dx.doi.org/10.1161/STROKEAHA.113.001238] [PMID: 23674531]
[http://dx.doi.org/10.1007/s11064-014-1316-0] [PMID: 24789365]
[http://dx.doi.org/10.1161/01.STR.24.1.35] [PMID: 7678184]
[http://dx.doi.org/10.1161/01.STR.20.7.864] [PMID: 2749846]
[http://dx.doi.org/10.1161/STROKEAHA.107.513655] [PMID: 18635847]
[http://dx.doi.org/10.1371/journal.pone.0129080] [PMID: 26047485]
[http://dx.doi.org/10.1097/CCM.0000000000000210] [PMID: 24557421]
[http://dx.doi.org/10.1016/j.mam.2008.05.001] [PMID: 18579197]
[http://dx.doi.org/10.1097/MCO.0b013e3282f2f4dd] [PMID: 18090651]
[http://dx.doi.org/10.3945/ajcn.113.082602] [PMID: 25057156]
[http://dx.doi.org/10.1161/CIRCULATIONAHA.106.673491] [PMID: 17309935]
[http://dx.doi.org/10.1001/jamaneurol.2014.755] [PMID: 24861877]
[http://dx.doi.org/10.1371/journal.pone.0069080] [PMID: 23935930]
[http://dx.doi.org/10.1007/s12020-012-9805-x] [PMID: 23015273]